availability of compounded semaglutide FDA Warns on Certain Forms Compounded Semaglutide (GLP-1) 3 Months

nih Jastreboff A.M., Kaplan L.M., Fras J.P., Wu Q., Du Y., Gurbuz S., Coskun T., Haupt A., Milicevic Z., Hartman M.L

If you take oral anticoagulants like warfarin, more frequent INR monitoring during tirzepatide initiation is advisable due to the potential for slowed absorption

Stopping cold turkey is a safe option, as long as your healthcare provider agrees thats the best option for you

GLP-1 Receptor Agonists for Weight Reduction in People Living with Obesity but without Diabetes: A Living Benefit-Harm Modelling Study. eClinicalMedicine (July 2024)

The safety data available derive from Phase 2 clinical trials (Jastreboff et al., NEJM, 2023), which, whilst informative, represent a relatively limited population and duration of follow-up compared to post-marketing surveillance